First Time in Nepal: Webinar on Blood

Nepalese Diaspora, are committed to maintain qualitative service of Blood in Nepal with collaboration of stakeholders of Nepal. Recently, they are working with Ministry of Health and Population of Nepal, Nepal Red Cross Society, Sanquin Blood Supply System.Non- Resident Nepali Association Blood Transfusion System Technology Transfer (NRNA BTS TT) under NRNA has planned to conduct webinar series: “Blood and Beyond” every month to sort out the problems which are concerned with blood transfusion and blood supply and to make more efficient system in Nepal.

On 28th April, 2019, NRNA BTS TT conducted webinar “Blood and Beyond ‘#Series1. ABO/ RH Typing, What is your patient?” in which there were about 40 participants onsite at Nepal Mediciti Hospital and about 30 participants online all over the world.

Nepal Mediciti Hospital for being a medical partner for our Webinar series, “BLOOD & BEYOND”. This is an initiation of the NRNA BTS TT to enhance the capacity of Blood Transfusion System in Nepal.  The main Speaker of the Program is Sabisha Shrestha MS BB (ASCP)CM who is certified Blood Bank Professional. She works at Children’s Hospital Colorado blood bank that provides transfusion to pediatric patients including trauma, cardiac and oncology patients.

They are thankful to Nepal Mediciti Hospital, Aspirenix and CHDS for their valuable support. They wanted to thank Sabisha Shrestha (Speaker), Dr. Bipin Nepal ( Grande Hsopital), Shrawan Kumar Shrestha (CBTSC, Nepal Red Cross Society), Suresh Gautam (Canada) and Drona Pandey who moderated , Dr. Gopi Aryal (Nepal Medicity Hospital) and Dr. Manita Raj Karnikar (Director,CBTSC) who were speakers as guest. Additionally,they thanked to all the participants online and onsite. Last but not the least, they express our gratitude to our team members who worked day and night for the making it successful.

Hence, it was the most effective program in the arena of blood management system for the first time in Nepal. It will be done every months. The next version of this program will be “Irregular antibody screening and possible significance in public health; but how?”